| BMY |
Bristol-Myers Squibb Company |
0 |
8.87% |
|
|
|
|
|
N/A |
0.00% |
29.35% |
18.78% |
|---|
| PFE |
Pfizer Inc. |
0 |
7.20% |
|
|
|
|
|
N/A |
0.00% |
19.74% |
1.40% |
|---|
| ABBV |
AbbVie Inc. |
0 |
7.09% |
|
|
|
|
|
N/A |
0.00% |
19.59% |
0.32% |
|---|
| JNJ |
Johnson & Johnson |
0 |
6.83% |
|
|
|
|
|
N/A |
0.00% |
16.09% |
13.59% |
|---|
| MRK |
Merck & Co., Inc. |
0 |
6.56% |
|
|
|
|
|
N/A |
0.00% |
26.14% |
20.02% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
4.60% |
|
|
|
|
|
N/A |
0.00% |
24.54% |
19.21% |
|---|
| CAH |
Cardinal Health, Inc. |
0 |
4.13% |
|
|
|
|
|
N/A |
0.00% |
23.93% |
21.92% |
|---|
| VTRS |
Viatris Inc. |
0 |
4.05% |
|
|
|
|
|
N/A |
0.00% |
31.49% |
14.92% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
3.75% |
|
|
|
|
|
N/A |
0.00% |
88.89% |
95.34% |
|---|
| JAZZ |
Jazz Pharmaceuticals plc |
0 |
3.56% |
|
|
|
|
|
N/A |
0.00% |
38.73% |
34.85% |
|---|
| ZTS |
Zoetis Inc. |
0 |
3.49% |
|
|
|
|
|
N/A |
0.00% |
23.88% |
10.93% |
|---|
| LLY |
Eli Lilly and Company |
0 |
3.19% |
|
|
|
|
|
N/A |
0.00% |
28.84% |
6.58% |
|---|
| AMGN |
Amgen Inc. |
0 |
3.07% |
|
|
|
|
|
N/A |
0.00% |
20.35% |
2.65% |
|---|
| BIIB |
Biogen Inc. |
0 |
2.90% |
|
|
|
|
|
N/A |
0.00% |
28.48% |
16.29% |
|---|
| OGN |
Organon & Co. |
0 |
2.42% |
|
|
|
|
|
N/A |
0.00% |
61.08% |
35.92% |
|---|
| CRL |
Charles River Laboratories International... |
0 |
2.40% |
|
|
|
|
|
N/A |
0.00% |
34.75% |
22.04% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
2.34% |
|
|
|
|
|
N/A |
0.00% |
32.11% |
31.90% |
|---|
| MEDP |
Medpace Holdings, Inc. |
0 |
1.86% |
|
|
|
|
|
N/A |
0.00% |
29.64% |
10.86% |
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
0 |
1.61% |
|
|
|
|
|
N/A |
0.00% |
24.23% |
9.87% |
|---|
| ELAN |
Elanco Animal Health Incorporated |
0 |
1.60% |
|
|
|
|
|
N/A |
0.00% |
30.35% |
8.69% |
|---|
| ALKS |
Alkermes plc |
0 |
1.13% |
|
|
|
|
|
N/A |
0.00% |
61.34% |
45.41% |
|---|
| EXEL |
Exelixis, Inc. |
0 |
1.12% |
|
|
|
|
|
N/A |
0.00% |
26.81% |
21.28% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
0 |
1.10% |
|
|
|
|
|
N/A |
0.00% |
40.62% |
12.80% |
|---|
| PBH |
Prestige Consumer Healthcare Inc. |
0 |
0.95% |
|
|
|
|
|
N/A |
0.00% |
72.97% |
26.54% |
|---|
| PRGO |
Perrigo Company plc |
0 |
0.95% |
|
|
|
|
|
N/A |
0.00% |
36.94% |
20.79% |
|---|
| CORT |
Corcept Therapeutics Incorporated |
0 |
0.79% |
|
|
|
|
|
N/A |
0.00% |
34.07% |
0.40% |
|---|
| TGTX |
TG Therapeutics, Inc. |
0 |
0.74% |
|
|
|
|
|
N/A |
0.00% |
50.57% |
19.94% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
0.69% |
|
|
|
|
|
N/A |
0.00% |
36.66% |
13.02% |
|---|
| ACLX |
Arcellx, Inc. |
0 |
0.63% |
|
|
|
|
|
N/A |
0.00% |
48.05% |
19.36% |
|---|
| ITCI |
Intra-Cellular Therapies, Inc. |
|
0.63% |
|
|
|
|
|
|
|
|
|
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
0.62% |
|
|
|
|
|
N/A |
0.00% |
34.56% |
17.63% |
|---|
| TWST |
Twist Bioscience Corporation |
0 |
0.60% |
|
|
|
|
|
N/A |
0.00% |
75.80% |
25.16% |
|---|
| VCEL |
Vericel Corporation |
0 |
0.59% |
|
|
|
|
|
N/A |
0.00% |
60.26% |
70.59% |
|---|
| INCY |
Incyte Corporation |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
31.53% |
32.12% |
|---|
| ADMA |
ADMA Biologics, Inc. |
0 |
0.55% |
|
|
|
|
|
N/A |
0.00% |
44.87% |
3.71% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
0.55% |
|
|
|
|
|
N/A |
0.00% |
34.98% |
22.10% |
|---|
| ROIV |
Roivant Sciences Ltd. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
38.83% |
65.35% |
|---|
| EXAS |
Exact Sciences Corporation |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
45.90% |
16.92% |
|---|
| BPMC |
Blueprint Medicines Corporation |
|
0.50% |
|
|
|
|
|
|
|
|
|
|---|
| AMRX |
Amneal Pharmaceuticals, Inc. |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
N/A |
23.10% |
|---|
| INSM |
Insmed Incorporated |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
42.54% |
16.40% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
88.39% |
43.42% |
|---|
| KRYS |
Krystal Biotech, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
34.82% |
16.27% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
0 |
0.45% |
|
|
|
|
|
N/A |
0.00% |
58.31% |
13.52% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
31.44% |
14.49% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
25.64% |
13.66% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
0 |
0.40% |
|
|
|
|
|
N/A |
0.00% |
57.46% |
55.59% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
0.36% |
|
|
|
|
|
N/A |
0.00% |
78.94% |
39.80% |
|---|
| VKTX |
Viking Therapeutics, Inc. |
0 |
0.34% |
|
|
|
|
|
N/A |
0.00% |
73.50% |
19.91% |
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
0.26% |
|
|
|
|
|
N/A |
0.00% |
73.30% |
28.32% |
|---|
|
US Dollar |
|
0.13% |
|
|
|
|
|
|
|
|
|
|---|